Figure 1. Delayed EAE disease onset in Olig1^−/− mice.

(A) EAE disease incidence in wild-type (WT; n = 17) and Olig1^−/− (n = 20) mice. (B) Clinical evaluation of WT and Olig1^−/− EAE mice during a period of 60 days after MOG immunization. (C) Clinical scores of WT and Olig1^−/− EAE mice in different stages.